跳至主要内容
临床试验/NCT05020743
NCT05020743终止不适用

A Natural History Study of Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)

Vigil Neuroscience, Inc.12 个研究点 分布在 6 个国家目标入组 56 人开始时间: 2021年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
56
试验地点
12
主要终点
Magnetic Resonance Imaging (MRI) Ventricle Volume

研究概览

简要总结

Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a rare, rapidly progressing, genetic, neurodegenerative disease for which no definitive treatment options and limited information on the natural history of the disease are available. The structural, genetic, and neuropathophysiological abnormalities of ALSP lead to the onset of neurologic symptoms, such as moderate to severe motor and neuropsychiatric impairments. This natural history study will collect data to contribute to the development of future novel therapies that focus on the neuropathophysiological features that underlie ALSP and that are essential to reverse, delay, or stop progression of this debilitating disorder.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Magnetic Resonance Imaging (MRI) Ventricle Volume

时间窗: Month 30

Change from Baseline in ventricle volume at Month 30

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验